¸ñÀû: This study aimed to investigate the influence of arterial
hypertension
(AH) on the manifestation of sensorineural hearing loss (SNHL) in
the
Kazakh population by analyzing the presence of specific genetic
polymorphisms through whole-genome sequencing. ¹æ¹ý:A total of 1200 patients underwent whole-genome sequencing to
identify
genetic polymorphisms associated with SNHL using data from the
GWAS
database. Among the 320 polymorphisms associated with SNHL, 52
were
genetically expressed in our patient cohort. Concurrently, all
patients
underwent comprehensive therapeutic and cardiological
examinations,
including assessment of hypertension severity, risk factors,
medication
usage, and laboratory test results. Audiological examinations
were
performed to confirm SNHL diagnosis. Patients were then divided
into a
case group (with AH and SNHL) and a control group (healthy
individuals
without AH and SNHL), with random assignment. °á°ú:Comparative analysis of the groups revealed a significantly higher
prevalence of dominant and recessive polymorphisms associated with SNHL
in the case group, with rates of 73% and 77%, respectively. In contrast,
the control group exhibited these polymorphisms at lower rates of 27%
and 23%. °á·Ð:The findings suggest a strong association between arterial
hypertension and the genetic predisposition to sensorineural
hearing
loss in the Kazakh population. The significantly higher
prevalence of
SNHL-related polymorphisms in hypertensive patients highlights
the
need for early audiological screening and targeted interventions
in
this high-risk group. Among the 52 identified polymorphisms, rs-
16864714, rs-1695, rs-17170356, rs-1878935, and rs-17287 were the
most
frequently expressed in our patients. |